TD Asset Management
ANRO icon

TD Asset Management’s Alto Neuroscience ANRO Stock Holding History

TD Asset Management’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.16M Hold
43,800
– – ﹤0.01% 1068
2026
Q1 		$985K Buy
+43,800
New +$812K ﹤0.01% 1093
2025
Q1 		– Sell
-110,792
Closed -$469K – 1282
2024
Q4 		$469K Buy
110,792
+33,800
+44% +$211K ﹤0.01% 1191
2024
Q3 		$932K Sell
76,992
-9,800
-11% -$120K ﹤0.01% 1201
2024
Q2 		$928K Buy
+86,792
New +$1.13M ﹤0.01% 1174

Other funds holding ANRO

AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSC
Spruce Street Capital New York $510M AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

TD Asset Management's ANRO Position: Q2 2026 in Review

TD Asset Management held its Alto Neuroscience (ANRO) position steady in Q2 2026 at 43,800 shares worth $1.16M. The position accounts for ﹤0.01% of the portfolio, ranked #1068.

TD Asset Management first reported a position in ANRO in Q2 2024 and has held it in 5 quarters since. 114 funds tracked by Wall St. Rank hold ANRO as of Q2 2026.

  • TD Asset Management held 43,800 shares of Alto Neuroscience worth $1.16M as of Q2 2026.
  • TD Asset Management left its Alto Neuroscience share count unchanged in Q2 2026.
  • Alto Neuroscience made up ﹤0.01% of TD Asset Management's portfolio in Q2 2026, its #1068 holding.
  • TD Asset Management first reported a position in Alto Neuroscience in Q2 2024 and has held it in 5 quarters since.
  • 114 funds tracked by Wall St. Rank held Alto Neuroscience as of Q2 2026.

Based on TD Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.